Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Enterprise Value: 2010-2024

Historic Enterprise Value for Sunshine Biopharma (SBFM) over the last 12 years, with Dec 2024 value amounting to -$3.7 million.

  • Sunshine Biopharma's Enterprise Value rose 69.71% to -$2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.7 million, marking a year-over-year increase of 42.66%. This contributed to the annual value of -$3.7 million for FY2024, which is 60.44% up from last year.
  • Sunshine Biopharma's Enterprise Value amounted to -$3.7 million in FY2024, which was up 60.44% from -$9.3 million recorded in FY2023.
  • In the past 5 years, Sunshine Biopharma's Enterprise Value registered a high of -$997,478 during FY2020, and its lowest value of -$9.3 million during FY2023.
  • In the last 3 years, Sunshine Biopharma's Enterprise Value had a median value of -$7.4 million in 2022 and averaged -$6.8 million.
  • As far as peak fluctuations go, Sunshine Biopharma's Enterprise Value tumbled by 1,974.15% in 2020, and later spiked by 60.44% in 2024.
  • Over the past 5 years, Sunshine Biopharma's Enterprise Value (Yearly) stood at -$997,478 in 2020, then slumped by 105.79% to -$2.1 million in 2021, then slumped by 259.10% to -$7.4 million in 2022, then decreased by 26.45% to -$9.3 million in 2023, then soared by 60.44% to -$3.7 million in 2024.